MassMutual Private Wealth & Trust FSB Raises Stock Holdings in Stryker Corporation $SYK

MassMutual Private Wealth & Trust FSB grew its position in Stryker Corporation (NYSE:SYK) by 6.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,875 shares of the medical technology company’s stock after acquiring an additional 4,313 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Stryker were worth $26,940,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Consolidated Portfolio Review Corp boosted its stake in Stryker by 4.2% during the 2nd quarter. Consolidated Portfolio Review Corp now owns 648 shares of the medical technology company’s stock worth $256,000 after purchasing an additional 26 shares during the period. Princeton Global Asset Management LLC increased its stake in Stryker by 16.9% in the second quarter. Princeton Global Asset Management LLC now owns 180 shares of the medical technology company’s stock valued at $71,000 after purchasing an additional 26 shares during the period. Sunflower Bank N.A. raised its holdings in shares of Stryker by 4.0% in the second quarter. Sunflower Bank N.A. now owns 696 shares of the medical technology company’s stock valued at $275,000 after buying an additional 27 shares during the last quarter. Pitti Group Wealth Management LLC boosted its stake in shares of Stryker by 3.2% during the second quarter. Pitti Group Wealth Management LLC now owns 861 shares of the medical technology company’s stock worth $341,000 after buying an additional 27 shares during the period. Finally, Sachetta LLC lifted its position in Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 27 shares during the period. 77.09% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Stryker

In related news, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $365.49, for a total value of $713,801.97. Following the sale, the chief accounting officer directly owned 2,833 shares in the company, valued at $1,035,433.17. The trade was a 40.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the stock in a transaction dated Thursday, November 6th. The shares were sold at an average price of $353.28, for a total transaction of $97,566,397.44. Following the completion of the sale, the director directly owned 2,702,108 shares in the company, valued at approximately $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 522,118 shares of company stock valued at $185,381,932 in the last 90 days. 5.20% of the stock is currently owned by insiders.

Stryker Trading Up 5.1%

Shares of Stryker stock opened at $366.46 on Wednesday. The company has a 50-day moving average of $359.75 and a two-hundred day moving average of $375.35. Stryker Corporation has a 12-month low of $329.16 and a 12-month high of $406.19. The company has a current ratio of 1.85, a quick ratio of 1.13 and a debt-to-equity ratio of 0.68. The stock has a market cap of $140.14 billion, a PE ratio of 48.16, a price-to-earnings-growth ratio of 2.23 and a beta of 0.89.

Stryker (NYSE:SYK) last released its quarterly earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share for the quarter, topping analysts’ consensus estimates of $3.13 by $0.06. Stryker had a return on equity of 24.07% and a net margin of 12.07%.The business had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. During the same quarter in the prior year, the firm posted $2.87 EPS. The company’s revenue was up 10.2% compared to the same quarter last year. On average, research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a $0.88 dividend. This is an increase from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Wednesday, December 31st. Stryker’s dividend payout ratio (DPR) is 46.25%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on SYK shares. Weiss Ratings reissued a “hold (c+)” rating on shares of Stryker in a report on Monday, December 22nd. Redburn Partners set a $420.00 price objective on shares of Stryker in a research report on Thursday, September 18th. Rothschild Redb raised shares of Stryker to a “hold” rating in a research note on Thursday, September 18th. Citigroup reduced their target price on shares of Stryker from $455.00 to $420.00 and set a “buy” rating for the company in a research note on Thursday, December 11th. Finally, UBS Group set a $408.00 target price on shares of Stryker in a report on Monday, October 13th. Fourteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Stryker presently has an average rating of “Moderate Buy” and an average target price of $430.40.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.